New data from egnite demonstrates opportunity to improve survival and reduce readmission rates for heart failure patients…
BACKGROUND Progression from moderate to severe aortic stenosis (AS) warrants careful monitoring due to the increased risk of sudden death and heart failure, with disease progression significantly varying among patients and no accurate predictive tools presently available. OBJECTIVE A Disease Progression Algorithm was developed from a deidentified database of 1,163,923
Octane’s annual High Tech Awards celebrates and recognizes individuals and companies who make Orange County a center of medical technology innovation.
We’re all familiar in clinical practice with many patients who, at least on first glance, look the same. If you look at the output of the echo report and database, two patients appear to fall under the moderate AS category but may have been undiagnosed with severe AS. The CardioCare
Congestive heart failure (CHF) results in poor patient outcomes and increases the cost of care particularly with recurrent CHF hospitalizations. Using the CardioCare platform…
© 2025 egnite, Inc. All Rights Reserved. egnite, egnite Inc., CardioCare, the heart logo, and the spark logo are trademarks of egnite, Inc. All other trademarks are property of their respective owners.
Privacy Policy Intellectual Property Terms of Use Implementation Kit Careers